1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 11-21-22 at 2:02pm, Licensing Program Analyst (LPA) Michael Bilger arrived unannounced to conduct a case management visit related to an incident reported on 11-15-22. LPA met with facility manager Dominic Maata and explained the purpose of the visit. Administrator Cleotilde Maria Brelin was notified of LPA's visit and purpose, and gave permission for facility manager to sign in her absence. LPA reviewed physician orders and care notes for resident1 (R1) and R2 and conducted facility tour. LPA also interviewed facility manager.
Based on interviews and record reviews, it was determined that R1 was treated on 11-9-22 for suspicion of scabies after skin was assessed by hospice physician. A medication cream was ordered by R1's physician and R1 was isolated as a result in a private room. On 11-14-22, R2 developed rashes and was treated as a precaution with medication cream ordered by R2's physician. Both R1 and R2 have received treatments as ordered. At this time follow up appointments are scheduled for R1 and R2 to further assess skin conditions. Isolation precautions remain in place for R1 and R2 including private rooms, isolation carts with PPE and infection control signage visable. A 30-day supply of PPE observed by LPA. All staff wearing masks. LPA checked for COVID symptoms prior to entering.
As a result, of today's visit, no citations are issued. An exit interview was conducted with Dominic Maata and a copy of this report was left with Dominic. |